Key Points. 1. The reversible fate of pirtobrutinib-tolerant persister cells in MCL is determined by the TCA cycle mode switch.2. Acetyl-CoA is a key metab
Designing randomized clinical trials (RCTs) that are fit for purpose to answer burning questions in routine practice is difficult, and the interpretation o
Key PointsS-MRD negativity <10–5 is the best predictor of outcomes in newly diagnosed multiple myeloma.Similar results are seen among patients who achie
Key PointsJAK2V617F neutrophils evade homeostatic clearance and accumulate in MPN owing to JAK2-STAT5–dependent upregulation of CD24.CD24 antibody blockade
Key PointsComplement MAC triggers the development of anti-CD36–mediated murine TRALI.Blockage of MAC formation by monoclonal anti-C7 prevented and ameliora
In this issue of Blood, Chen et al have identified the membrane attack complex (MAC) as a key mediator in anti-CD36-mediated murine transfusion-related acu
In this issue of Blood, Felder et al1 demonstrate that, for normal developmental control of globin gene expression, the enhancer (locus control region [LCR
The American Society of Hematology (ASH) is in search of Associate Editors to join ASH Clinical News, the Society’s monthly news magazine for the broader…
In this issue of Blood, Giri et al report that sustained minimal residual disease (MRD) negativity at the 10−5 threshold is the most effective predictor…
In this issue of Blood, Corre et al1 present the final, long-term minimal residual disease (MRD) and progression-free survival (PFS) results from the multi
Second Look- Rapid Review Program | Journals Gateway | American Society of Hematology Second Look – Rapid Response Program The Second Look program provides you…
